150 related articles for article (PubMed ID: 2728555)
1. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
Beykirch H; Reuter W; Voigt H; Herrmann W
Z Gesamte Inn Med; 1989 Feb; 44(3):77-9. PubMed ID: 2728555
[TBL] [Abstract][Full Text] [Related]
2. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
[No Abstract] [Full Text] [Related]
3. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
Regenthal R; Voigt H; Reuter W; Preiss R
Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
[TBL] [Abstract][Full Text] [Related]
4. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
Berent H; Kancelarczyk WL; Zebrowski M; Uchman B
Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518
[No Abstract] [Full Text] [Related]
5. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
Cavaller JM; Samper JC
Med Monatsschr; 1976 Jul; 30(7):323-6. PubMed ID: 790140
[No Abstract] [Full Text] [Related]
6. [Oral trapidil treatment of Fontaine stage II arteriosclerotic circulatory disorders of the legs--a double-blind study].
Voigt H; Reuter W; Hofmann B; Dobberkau A
Z Gesamte Inn Med; 1990 May; 45(10):283-7. PubMed ID: 2392858
[TBL] [Abstract][Full Text] [Related]
7. [Effect of treatment with trental on indicators of peripheral hemodynamics and blood lipid level in patients with arteriosclerosis of the lower extremities].
Sidorenko GI; Tsapaev VG; Tsapaeva NL; Atroshchenko ES
Kardiologiia; 1987 Nov; 27(11):77-80. PubMed ID: 3437669
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of vascular diseases of the extremities using pentoxifylline].
Di Perri T
Ric Clin Lab; 1988; 18 Suppl 2():49-56. PubMed ID: 3073515
[No Abstract] [Full Text] [Related]
9. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
Chyzy R; Lukjan H; Rość D; Bielawiec M; Sawicka J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
[TBL] [Abstract][Full Text] [Related]
10. [Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries].
Atroshchenko ES
Kardiologiia; 1986 Dec; 26(12):106-8. PubMed ID: 3550207
[No Abstract] [Full Text] [Related]
11. Pentoxifylline--a new drug for the treatment of intermittent claudication.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Schweiger H; Ortmeier CJ
Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
Strano A; Davì G; Novo S; Avellone G; Pinto A
Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
[No Abstract] [Full Text] [Related]
14. [Intermittent claudication treated with pentoxifylline. A controlled trial].
Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
[No Abstract] [Full Text] [Related]
15. [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
Dembińska-Kieć A; Kostka-Trabka E; Grodzińska L; Bieroń K; Kedzior A; Basista M; Zmuda A; Trabka E; Slawiński M; Czarnecka H
Fortschr Med; 1989 Jul; 107(20):450-2. PubMed ID: 2767596
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
17. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
Antignani PL; Todini AR; Saliceti F; Pacino G; Bartolo M
Pharmatherapeutica; 1987; 5(1):50-6. PubMed ID: 3602022
[TBL] [Abstract][Full Text] [Related]
18. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
Chacón-Quevedo A; Eguaras MG; Calleja F; Garcia MA; Roman M; Casares J; Muñoz I; Concha M
Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
[TBL] [Abstract][Full Text] [Related]
20. [Pentoxifylline and prostaglandins].
Poggesi L; Boddi M; Scarti L; Masotti G
Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659
[No Abstract] [Full Text] [Related]
[Next] [New Search]